Cellulitis and erysipelas are two common skin infections that can cause red, swollen, and tender skin. Both are bacterial infections, but they have some important differences. This article takes a closer look at the differences between cellulitis and erysipelas, including their causes, symptoms, and treatments.
Cellulitis and erysipelas are both caused by bacterial infections. Cellulitis is usually caused by streptococcus or staphylococcus bacteria, while erysipelas is usually caused by the bacterium Streptococcus pyogenes. The bacteria that cause cellulitis and erysipelas can enter the body through a break in the skin, such as a cut, scrape, burn, or insect bite. They can also enter through a surgical wound or an area of skin that has been weakened by another infection, such as athlete’s foot or eczema.
The main symptom of both cellulitis and erysipelas is red, swollen, and tender skin. In both cases, the affected area may also be warm to the touch. Cellulitis can affect any area of the body, but it is most common on the face, arms, and legs. Erysipelas usually affects the face, especially the cheeks and the bridge of the nose. Other symptoms of cellulitis include fever, chills, fatigue, and swollen lymph nodes. Symptoms of erysipelas include fever, chills, and a bright red rash that may have a raised, scaly border.
Cellulitis and erysipelas can be difficult to distinguish from each other, so it is important to see a doctor for a proper diagnosis. To diagnose the infection, the doctor will examine the affected area and ask about your symptoms. They may also take a sample of the affected area and send it to a laboratory for testing.
The treatment for cellulitis and erysipelas is usually antibiotics, either taken orally or applied directly to the affected area. The type of antibiotic used will depend on the type of bacteria causing the infection. In some cases, the doctor may also recommend pain relievers, such as ibuprofen or acetaminophen, to help relieve pain and swelling. If the infection is severe, the doctor may also recommend hospitalization and intravenous antibiotics.
To help prevent cellulitis and erysipelas, it is important to keep the skin clean and dry, and to avoid cuts, scrapes, and insect bites. It is also important to treat any existing skin conditions, such as athlete’s foot or eczema, to reduce the risk of infection.
Cellulitis and erysipelas are two common bacterial skin infections that can cause red, swollen, and tender skin. Although they have some similarities, they also have some important differences. It is important to see a doctor for a proper diagnosis and treatment. To help prevent these infections, it is important to keep the skin clean and dry, and to treat any existing skin conditions.
1.
EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues
2.
Universal screening approach achieves a comparable detection rate of lung cancer
3.
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
4.
The response of bipolar patients to lithium may be predicted by ancestry.
5.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
1.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
2.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
3.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
4.
Precision Supportive Oncology: Managing Immune Toxicity, Treatment-Related Critical Illness and Long-Term Quality of Life
5.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Understanding the Role of Screening in Cancer Prevention
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XII
5.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation